S&P Futures
5,759.50 +21.00 (+0.37%) Dow Futures
42,097.00 +150.00 (+0.36%) Nasdaq Futures
20,106.25 +84.50 (+0.42%) Russell 2000 Futures
2,210.50 +1.90 (+0.09%) Crude Oil
70.70 +1.44 (+2.08%) Gold
2,761.70 +12.40 (+0.45%)
Outset Medical, Inc. (OM)
After hours:
| Previous Close | 0.5399 |
| Open | 0.5210 |
| Bid | 0.4061 x 200 |
| Ask | 0.6787 x 200 |
| Day's Range | 0.5201 - 0.5853 |
| 52 Week Range | 0.4350 - 6.3700 |
| Volume | |
| Avg. Volume | 1,884,785 |
| Market Cap | 29.691M |
| Beta (5Y Monthly) | 1.93 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.1400 |
| Earnings Date | Nov 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.15 |
GlobeNewswireNew Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo
Outset Medical features patient experience posterpresentations at Kidney Week 2024 Consensus recommendations for use of catheters in home hemodialysis patients published in Kidney Medicine SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset″), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced two new research posters that demonstrate significant quality of life and menta
- GlobeNewswire
Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Wednesday, November 6, 2024. On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chie
